Scarica l'app Stockscreener
48.82
1.43%
0.69
Dopo l'orario di chiusura:
49.00
0.18
+0.37%
Precedente Chiudi:
$48.13
Aprire:
$47.75
Volume 24 ore:
436.33K
Relative Volume:
0.71
Capitalizzazione di mercato:
$3.74B
Reddito:
$677.56M
Utile/perdita netta:
$59.01M
Rapporto P/E:
65.50
EPS:
0.7453
Flusso di cassa netto:
$136.42M
1 W Prestazione:
+4.36%
1M Prestazione:
+6.13%
6M Prestazione:
+30.29%
1 anno Prestazione:
+123.43%
Intervallo 1D:
$46.82
$48.85
Intervallo di 1 settimana:
$44.76
$49.33
Portata 52W:
$18.25
$49.33
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
Nome
Kiniksa Pharmaceuticals International Plc
Settore
Telefono
(781) 431-9100
Indirizzo
105 PICCADILLY, SECOND FLOOR, LONDON
Compare KNSA vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KNSA
Kiniksa Pharmaceuticals International Plc
|
48.82 | 3.74B | 677.56M | 59.01M | 136.42M | 0.7453 |
TAK
Takeda Pharmaceutical Co Adr
|
18.74 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
117.94 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.93 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.08 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
564.81 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-29 | Iniziato | TD Cowen | Buy |
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2024-05-03 | Iniziato | Wells Fargo | Overweight |
| 2020-06-29 | Reiterato | BofA Securities | Buy |
| 2020-04-01 | Iniziato | BofA/Merrill | Buy |
| 2019-03-11 | Iniziato | Barclays | Overweight |
| 2018-12-12 | Reiterato | Wedbush | Outperform |
| 2018-06-19 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Kiniksa Pharmaceuticals International Plc Borsa (KNSA) Ultime notizie
If You Invested $1,000 in Kiniksa Pharmaceuticals International, plc (KNSA) - Stock Titan
KNSA PE Ratio & Valuation, Is KNSA Overvalued - intellectia.ai
[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity - Stock Titan
Kiniksa (KNSA) CFO receives new options, RSUs and PSUs in 2026 award - Stock Titan
Kiniksa (NASDAQ: KNSA) CEO awarded options, RSUs and PSUs, covers tax - Stock Titan
Kiniksa (KNSA) CMO granted options, RSUs and PSUs in equity awards - Stock Titan
Kiniksa (KNSA) COO receives major equity awards and exercises RSUs - Stock Titan
Kiniksa (KNSA) CAO receives options, RSUs, PSUs and adds to shareholdings - Stock Titan
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Fits the Minervini Trend Template with High-Growth Momentum - ChartMill
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Kiniksa Pharmaceuticals International, plc (KNSA) stock price, news, quote and history - Yahoo Finance Singapore
KNSA Should I Buy - intellectia.ai
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 1-Year HighShould You Buy? - MarketBeat
Hennion & Walsh Asset Management Inc. Trims Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa's discounted P/S ratio reflects investor caution amid weak growth forecasts. Sentiment may not turn bullish unless the company delivers stronger-than-expected revenue growth. - Moomoo
JPMorgan Chase & Co. Has $7.47 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Vanguard realignment leads to 0-share filing for Kiniksa (KNSA) - Stock Titan
SG Americas Securities LLC Has $22.33 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International PLC (KNSA) Trading 3.48% H - GuruFocus
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Presents a High-Growth Momentum Setup - ChartMill
Kiniksa raises ARCALYST 2025 revenue guidance to $605M amid strong Q1 performance - msn.com
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top GARP Investment - ChartMill
Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Recent Share Price Pullback - Yahoo Finance
Kiniksa Pharmaceuticals International, plc Q4 2025 earnings preview - MSN
Kiniksa Pharmaceuticals International PLC (KNSA) Stock Price Up 3.67% on Mar 16 - GuruFocus
Granahan Investment Management LLC Sells 27,421 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by Braidwell LP - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by ArrowMark Colorado Holdings LLC - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Acquires 101,666 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
FMR LLC's Strategic Acquisition of Kiniksa Pharmaceuticals Shares - GuruFocus
Kiniksa (KNSA) CFO sells 36,722 shares after exercising options - Stock Titan
Kiniksa (NASDAQ: KNSA) insider sale notice lists 36,722 shares (Rule 144) - Stock Titan
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going - MSN
FMR LLC holds 10.6% of Kiniksa (KNSA) — 4.85M shares reported - Stock Titan
Why Kiniksa Pharmaceuticals International, plc (KNSA) is Poised to Beat Earnings Estimates Again - MSN
Vanguard Group Inc. Trims Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shows Strong Growth and Bullish Chart Setup - ChartMill
Fisher Asset Management LLC Acquires 180,029 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals CMO Sells Shares Worth Nearly $1.8 Million - TradingView
Kiniksa Pharmaceuticals (KNSA) CMO sells 40K shares after option exercise - Stock Titan
How Investors Are Reacting To Kiniksa (KNSA) Turning ARCALYST Revenue Into Full-Year Profitability And Flexibility - simplywall.st
Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Robust Growth Potential With 23% Upside - DirectorsTalk Interviews
Kiniksa (NASDAQ: KNSA) Rule 144 notice: 40,000-share cashless exercise - Stock Titan
KNSA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Kiniksa Pharmaceuticals (NASDAQ:KNSA): A Prime Example of Affordable Growth (GARP) Investing - ChartMill
Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Recent Share Price Volatility - Yahoo Finance
KNSA/N Stock Price and Chart — BIVA:KNSA/N - TradingView
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewswire
The Analyst Verdict: Kiniksa Pharmaceuticals In The Eyes Of 4 Experts - Benzinga
Kiniksa Pharmaceuticals International Plc Azioni (KNSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):